164 related articles for article (PubMed ID: 6171518)
1. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
Oguma K; Syuto B; Agui T; Iida H; Kubo S
Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
[TBL] [Abstract][Full Text] [Related]
3. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
Oguma K; Syuto B; Iida H; Kubo S
Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
[TBL] [Abstract][Full Text] [Related]
4. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.
Oguma K; Agui T; Syuto B; Kimura K; Iida H; Kubo S
Infect Immun; 1982 Oct; 38(1):14-20. PubMed ID: 6183207
[TBL] [Abstract][Full Text] [Related]
5. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
Moriishi K; Syuto B; Kubo S; Oguma K
Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
[TBL] [Abstract][Full Text] [Related]
6. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
Notermans S; Dufrenne J; Kozaki S
Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
[TBL] [Abstract][Full Text] [Related]
7. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
Eklund MW; Poysky FT
Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
[TBL] [Abstract][Full Text] [Related]
8. Clostridium botulinum subtype Ba.
Giménez DF
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneities of two components of C2 toxin produced by Clostridium botulinum types C and D.
Ohishi I; Okada Y
J Gen Microbiol; 1986 Jan; 132(1):125-31. PubMed ID: 3086490
[TBL] [Abstract][Full Text] [Related]
10. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
[TBL] [Abstract][Full Text] [Related]
11. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.
Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G
Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459
[TBL] [Abstract][Full Text] [Related]
12. Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.
Kozaki S; Miyazaki S; Sakaguchi G
Infect Immun; 1977 Dec; 18(3):761-6. PubMed ID: 412790
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies.
Oguma K; Murayama S; Syuto B; Iida H; Kubo S
Infect Immun; 1984 Feb; 43(2):584-8. PubMed ID: 6198281
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.
Mahmut N; Inoue K; Fujinaga Y; Arimitsu H; Sakaguchi Y; Hughes L; Hirst R; Murphy T; Tsuji T; Watanabe T; Ohyama T; Karasawa T; Nakamura S; Yokota K; Oguma K
J Med Microbiol; 2002 Oct; 51(10):813-820. PubMed ID: 12435059
[TBL] [Abstract][Full Text] [Related]
15. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
Giménez JA; Sugiyama H
Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.
Tsuzuki K; Yokosawa N; Syuto B; Ohishi I; Fujii N; Kimura K; Oguma K
Infect Immun; 1988 Apr; 56(4):898-902. PubMed ID: 2450068
[TBL] [Abstract][Full Text] [Related]
17. Purification and properties of Clostridium botulinum type F toxin.
Yang KH; Sugiyama H
Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
[TBL] [Abstract][Full Text] [Related]
18. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
Rymkiewicz D; Sawicki J; Brühl A
Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
[TBL] [Abstract][Full Text] [Related]
19. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
Gimenez DF; Ciccarelli AS
Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
[No Abstract] [Full Text] [Related]
20. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
